Compliance certificate under SEBI Reg 74(5) for Q2 FY27

Compliance View source PDF Explain this filing

ANTHEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.4%Reaction day

₹865.90

prior close

₹862.30

announcement price

After-mkt

timing

Nifty Midcap 150market+0.1%+1.3% vs market

Biotechnology peers, median of 5sector+0.0%+1.4% vs sector

On the reaction day the stock moved 1.3 pts more than Nifty Midcap 150 and 1.4 pts more than its Biotechnology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.4

10m

+1.2

15m

+1.6

30m

+1.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.4+0.1+1.3+0.0+1.4

Next day

+0.5+1.0-0.6-0.2+0.7

-2.2+1.0-3.2+1.1-3.3

-3.0+0.7-3.7——

-4.8+0.6-5.4+0.4-5.1

-7.2-0.5-6.7-1.2-6.0

-7.6-2.7-5.0-1.0-6.6

15d

—————

UpDownMarket · Nifty Midcap 150Sector · Biotechnology peers, median of 5Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Anthem Biosciences filed a routine compliance certificate from its Registrar Kfin Technologies for the quarter ended September 30, 2026. The certificate confirms that all details of shares dematerialized and rematerialized during the quarter were furnished to BSE and NSE as required under SEBI Depository Regulations. This is a standard procedural filing.

Likely market impact

Routine procedural compliance filing. No material impact on business or shareholders.